All articles
Drug Research
Alosetron: case study in regulatory capture, or victory for patients’ rights? – (09-19-02)
James Bogash
Alosetron: case study in regulatory capture, or victory for patients’ rights?
This article brings to light the scary concept that the FDA is funded strongly by the pharmaceutical companies they are supposed to regulate. Does anyone get a little nervous about this association besides me?
bmj.com Moynihan 325 (7364): 592
